In 2023, the mortality rate for colon, rectum, and anus malignant neoplasms in the US was a key metric. The forecast data for 2024 to 2028 indicates a steady decline in mortality rates: from 14.6 deaths per 100,000 persons in 2024 to 13.2 in 2028. This downward trend, compounded by a consistent year-on-year decrease, reflects enhanced screening, advances in treatment, and possibly lifestyle changes. The forecasted CAGR indicates a substantial improvement over the next five years.
Future trends to watch for include the impact of innovations in personalized medicine and early detection methods. Ongoing public health initiatives and awareness campaigns will likely continue to contribute to this positive trend. Monitoring demographic shifts and healthcare access disparities will also be crucial for effective intervention strategies.
